Polar Capital Holdings’s Bristol-Myers Squibb BMY Stock Holding History

Polar Capital Holdings’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-437,401	Closed	-$31.9K	–	441
2022 Q1	$31.9K	Sell	437,401 -598,500	-58%	-$40.2M	0.14%	127
2021 Q4	$64.6K	Sell	1,035,901 -740,367	-42%	-$43.4M	0.24%	87
2021 Q3	$105K	Buy	1,776,268 +1,402,425	+375%	+$92.4M	0.43%	49
2021 Q2	$25K	Buy	373,843 +25,000	+7%	+$1.63M	0.11%	148
2021 Q1	$22M	Buy	348,843 +16,000	+5%	+$995K	0.14%	147
2020 Q4	$20.6M	Buy	+332,843	New	+$20.5M	0.13%	155

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Polar Capital Holdings's BMY Position: Q2 2022 in Review

Polar Capital Holdings sold out of Bristol-Myers Squibb (BMY) in Q2 2022, closing a stake of 437,401 shares — an estimated $31.9K sold.

Polar Capital Holdings first reported a position in BMY in Q4 2020 and held it in 6 quarters. The position peaked at $22M in Q1 2021. 2,537 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

Polar Capital Holdings reported no remaining Bristol-Myers Squibb position as of Q2 2022 after selling out during the quarter.
Polar Capital Holdings sold 437,401 Bristol-Myers Squibb shares in Q2 2022, an estimated $31.9K.
Polar Capital Holdings first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 6 quarters.
Polar Capital Holdings's Bristol-Myers Squibb position peaked at $22M in Q1 2021.
2,537 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on Polar Capital Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.